Clover Health Investments Corp
F:7QD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Clover Health Investments Corp
F:7QD
|
US |
|
M
|
Monster Beverage Corp
F:MOB
|
US |
|
B
|
Bunge Ltd
F:BU3
|
US |
|
A
|
Auckland International Airport Ltd
F:BZTA
|
NZ |
|
Barratt Developments P L C
LSE:BDEV
|
UK |
|
Zscaler Inc
F:0ZC
|
US |
|
M
|
Mitsubishi Estate Co Ltd
XMUN:MES
|
JP |
|
S
|
Supernus Pharmaceuticals Inc
SWB:S49
|
US |
|
First Commonwealth Financial Corp
NYSE:FCF
|
US |
|
S
|
Seafco PCL
SET:SEAFCO
|
TH |
Wall St Price Targets
7QD Price Targets Summary
Clover Health Investments Corp
According to Wall Street analysts, the average 1-year price target for
7QD is 1.75 EUR with a low forecast of 0.86 EUR and a high forecast of 2.42 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 7QD's stock price target?
Price Target
1.75
EUR
According to Wall Street analysts, the average 1-year price target for
7QD is 1.75 EUR with a low forecast of 0.86 EUR and a high forecast of 2.42 EUR.
What is the Revenue forecast for Clover Health Investments Corp?
Projected CAGR
25%
The compound annual growth rate for Revenue over the next 3 years is 25%.